AngioDynamics (ANGO) Competitors $9.59 +0.20 (+2.13%) Closing price 07/3/2025 02:41 PM EasternExtended Trading$9.59 0.00 (0.00%) As of 07/3/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical AngioDynamics (NASDAQ:ANGO) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability. Is ANGO or TMO more profitable? Thermo Fisher Scientific has a net margin of 15.19% compared to AngioDynamics' net margin of -14.61%. Thermo Fisher Scientific's return on equity of 17.15% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets AngioDynamics-14.61% -3.73% -2.43% Thermo Fisher Scientific 15.19%17.15%8.47% Do analysts rate ANGO or TMO? AngioDynamics currently has a consensus target price of $14.00, suggesting a potential upside of 45.99%. Thermo Fisher Scientific has a consensus target price of $604.05, suggesting a potential upside of 41.05%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts clearly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has better earnings & valuation, ANGO or TMO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAngioDynamics$303.91M1.28-$184.35M-$1.01-9.50Thermo Fisher Scientific$42.88B3.77$6.34B$17.0525.12 Does the media refer more to ANGO or TMO? In the previous week, Thermo Fisher Scientific had 57 more articles in the media than AngioDynamics. MarketBeat recorded 58 mentions for Thermo Fisher Scientific and 1 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.54 beat Thermo Fisher Scientific's score of 1.28 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Thermo Fisher Scientific 45 Very Positive mention(s) 7 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in ANGO or TMO? 89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 5.4% of AngioDynamics shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, ANGO or TMO? AngioDynamics has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. SummaryThermo Fisher Scientific beats AngioDynamics on 11 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$389.02M$6.86B$5.53B$9.05BDividend YieldN/A1.21%5.24%4.03%P/E Ratio-9.5026.1527.5220.22Price / Sales1.2899.70421.02118.64Price / Cash2.2321.0936.8958.07Price / Book1.874.748.045.67Net Income-$184.35M$173.18M$3.18B$249.13M7 Day Performance-1.94%1.33%2.90%3.28%1 Month Performance-12.50%0.16%3.70%5.55%1 Year Performance72.48%23.71%36.15%21.12% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics3.9821 of 5 stars$9.59+2.1%$14.00+46.0%+68.8%$389.02M$303.91M-9.50760Positive NewsTMOThermo Fisher Scientific4.9939 of 5 stars$405.83-0.6%$604.05+48.8%-20.0%$154.12B$42.88B23.80125,000Positive NewsWSTWest Pharmaceutical Services4.7576 of 5 stars$218.800.0%$320.00+46.3%-30.9%$15.72B$2.89B34.3510,600IARTIntegra LifeSciences4.0762 of 5 stars$12.27-0.2%$18.63+51.8%-53.1%$955.08M$1.61B-32.294,396OFIXOrthofix Medical3.1028 of 5 stars$11.15+0.5%$21.50+92.8%-17.7%$434.52M$799.49M-3.021,616Gap UpSRDXSurmodics4.2086 of 5 stars$29.71+3.1%$43.00+44.7%-28.6%$411.96M$126.08M-21.37450News CoverageAnalyst RevisionARAYAccuray3.6345 of 5 stars$1.37-0.7%N/A-17.7%$142.16M$446.55M-27.401,040Positive NewsRMTIRockwell Medical4.0868 of 5 stars$0.85+7.1%$4.00+371.7%-51.5%$27.07M$101.49M-42.40300RSLSReShape Lifesciences0.1138 of 5 stars$2.44flatN/A-99.3%$5.82M$8.01M-0.0150ABTAbbott Laboratories4.8916 of 5 stars$136.09+1.3%$142.61+4.8%+30.7%$233.80B$41.95B17.65114,000Positive NewsISRGIntuitive Surgical4.3409 of 5 stars$543.41+1.8%$588.95+8.4%+25.1%$191.29B$8.35B79.6815,638Positive News Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANGO Stock Alerts